Ovestin (Estriol)

Estriol, the active ingredient in Ovestin, is a estrogen hormone presented as a vaginal cream for topical use. It is employed to address estrogen deficiency‑related urogenital symptoms in post‑menopausal women. GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Estriol acts on the estrogen pathway to relieve urogenital manifestations of menopause and to support hormone replacement regimens. - Menopausal vulvovaginal atrophy: improves vaginal dryness, irritation and dyspareunia. - Postmenopausal estrogen deficiency: alleviates mild urogenital discomfort and urinary symptoms. - Adjunct in hormone replacement therapy: contributes to systemic estrogen balance in selected patients.

Estriol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Vaginal irritation or burning sensation - Increased vaginal discharge or spotting - Itching or mild rash at the application site - Headache - Breast tenderness - Nausea

Serious or Rare Side Effects: - Endometrial hyperplasia or abnormal uterine bleeding - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Severe allergic reaction (anaphylaxis, angioedema) - Uterine perforation (very rare) - Severe skin rash or Stevens‑Johnson syndrome - Hepatic dysfunction in susceptible individuals

Before initiating estriol therapy, clinicians should evaluate individual risk factors and contraindications. - Assess estrogen status: confirm indication and baseline hormone levels. - Avoid in estrogen‑dependent neoplasia: contraindicated in known breast or uterine cancer. - Monitor for thromboembolic risk: use caution in patients with clotting disorders or a history of thrombosis. - Consider liver function: adjust or avoid in severe hepatic impairment. - Pregnancy and lactation: not recommended due to limited safety data. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Estriol can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Combined oral contraceptives: increased estrogen load may raise clotting risk. - Anticoagulants (e.g., warfarin): may potentiate bleeding tendencies. - Selective estrogen receptor modulators (SERMs): antagonistic hormonal effects.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: estriol may affect thyroid‑binding globulin levels. - Antihypertensives: possible fluid retention may modify blood pressure control. - CYP450 inducers (e.g., rifampicin): may reduce estriol plasma concentrations.